SOURCE: University General Health System, Inc.

University General Health System, Inc.

April 17, 2012 08:28 ET

University General Health System, Inc. Revenue Increases 29% to $72.5 Million in 2011

Shareholders' Equity Improves by $38 Million in Year Ended December 31, 2011

HOUSTON, TX--(Marketwire - Apr 17, 2012) - University General Health System, Inc. (OTCQB: UGHS) (PINKSHEETS: UGHS), a diversified, integrated multi-specialty health delivery system, today announced its 2011 operating results, including a 29% improvement in total revenue, an increase in shareholders' equity of $38 million, and an increase in assets of $48.1 million.

Highlights for the year ended December 31, 2011:

  • Net patient revenue increased 22% to approximately $68.3 million, compared with approximately $55.9 million in the year ended December 31, 2010. Average daily inpatient census at the Company's flagship University General Hospital in Houston increased by 38.5% in 2011 relative to prior-year levels.
  • Resident revenue for the senior living business segment approximated $3.6 million, support services revenue totaled $465,639, and other revenue totaled $174,211 in 2011. The senior living properties reported an overall occupancy of 92.2% in the year ended December 31, 2011. This was higher than the senior living industry's national average occupancy of 87.8% for combined properties as reported by the National Investment Center for the Senior Housing and Care Center for the fourth quarter 2011.
  • Total revenue rose approximately 29% to $72.5 million, compared with $56.1 million in 2010. Total revenue in 2011 included partial-year revenue from senior living and support services business segments that were acquired during the second half of 2011.
  • Net patient revenue from Medicare and Medicaid accounted for approximately 34.5% and 31.7% of total net patient revenue, and revenue from managed care contracts and other third party payors accounted for approximately 54.3% and 56.0% of net patient revenue in 2011 and 2010, respectively.
  • Total assets increased 72% to $114.7 million as of December 31, 2011, compared with $66.5 million at December 31, 2010.
  • Shareholders' equity improved by $38 million, from a negative ($38.1 million) at December 31, 2010 to a negative ($0.4 million) at December 31, 2011.
  • EBITDA declined slightly to $9.6 million in 2011, versus $10.3 million in 2010. (EBITDA is a non-GAAP measure that is reconciled with GAAP results in a table at the end of this press release.).
  • Operating income decreased to approximately $2.5 million in 2011, versus approximately $3.4 million in the previous year, primarily due to increased staffing and other costs associated with the implementation of an aggressive internal and external growth strategy, along with one-time costs associated with going public and an increase in management fees that were attributable to certain acquisitions.
  • The Company recorded a net loss attributable to common shareholders of ($2.6 million), or ($0.01) per share, in the most recent year, compared with a net loss attributable to common shareholders of ($1.7 million), or ($0.01) per share, in 2010.

"Our 29% increase in total revenue during 2011 was primarily attributable to a 38.5% increase in the average daily census at University General Hospital, higher net patient collections, the opening of a Hyperbaric Wound Care Center, and the mid-year acquisitions of TrinityCare Senior Living and Autimis," commented Dr. Hassan Chahadeh, M.D., Chairman and Chief Executive Officer of University General Health System, Inc. "While operating income decreased 26% for the year, partially due to higher staffing and other costs associated with the implementation of an aggressive organic growth and acquisition strategy, we were very pleased that EBITDA declined only 6%, in spite of the costs associated with going public."

"University General Health System enters 2012 as a much stronger company that is well-positioned to execute its growth strategy. Supported by a stronger balance sheet, our objectives for 2012 include the pursuit of additional acquisitions to build out our regional health care system in the Houston area, and we may expand into one or more new markets, as well. Longer-term, we plan to capitalize on opportunities created by the current regulatory and reimbursement environment, through acquisitions and expansions, to develop diversified, integrated, multi-specialty health care delivery networks comprised of flagship acute care hospitals that are supported by complementary free-standing hospital outpatient departments (HOPDs) in each market. One of our primary goals for 2012 is to advance a physician-centric operating model that bonds independent physicians and medical groups to our hospital and facilities through value-added partnering, management and service arrangements. We expect these efforts, among other factors, to result in substantial improvements in the Company's financial performance in 2012."

Use of Non-GAAP Financial Measures

Adjusted EBITDA

Adjusted EBITDA is a measure of operating performance that is not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). Adjusted EBITDA should not be considered in isolation or as a substitute for net income (loss), income from operations or cash flows provided by or used in operations, as determined in accordance with GAAP. Adjusted EBITDA is a key measure of the Company's operating performance used by management to focus on operating performance and management without mixing in items of income and expense that relate to the financing and capitalization of the business. The Company defines Adjusted EBITDA as net income (loss) before provision (benefit) for income taxes, non-operating (income) expense items, (gain) loss on sale of assets, depreciation and amortization (including non-cash impairment charges), amortization of deferred gain, and non-cash stock-based compensation expense.

The Company believes Adjusted EBITDA is useful to investors in evaluating our performance, results of operations and financial position for the following reasons:

  • It is helpful in identifying trends in day-to-day performance because the items excluded have little or no significance to day-to-day operations;
  • It provides an assessment of controllable expenses and affords management the ability to make decisions that are expected to facilitate meeting current financial goals and achieve optimal financial performance; and
  • It is an indication of whether adjustments to current spending decisions are necessary.

About University General Health System, Inc.

University General Health System, Inc. ("University General") is a diversified, integrated multi-specialty health care provider that delivers concierge physician and patient-oriented services by providing timely, innovative health solutions that are uniquely competitive, efficient, and adaptive in today's health care delivery environment. The Company currently operates one hospital, two ambulatory surgical centers and a Hyperbaric Wound Care Center (HBOT) in the Houston area. Also, University General owns three senior living facilities and manages six senior living facilities, and it plans to complete multiple additional developments in the near future in Houston and other strategic markets. University General also owns a Support Services company that includes a revenue cycle and luxury facilities management company.

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company's periodic filings with the Securities and Exchange Commission.

(Financial Highlights Follow)

Consolidated Balance Sheets
December 31 December 31,
2011 2010
Current assets
Cash and cash equivalents $ 538,018 $ 2,291,754
Accounts receivables, net 10,913,361 8,312,184
Inventories 1,908,177 1,765,735
Receivables from related parties 658,764 633,678
Prepaid expenses and other assets 1,275,104 52,790
Total current assets 15,293,424 13,056,141
Investments in unconsolidated affiliates 687,323 -
Property and equipment, net 77,012,883 53,224,152
Intangible assets 1,140,000 -
Goodwill 18,299,310 -
Other assets 2,234,985 266,603
Total assets $ 114,667,925 $ 66,546,896
Current liabilities
Accounts payable $ 11,874,720 $ 14,823,508
Payables to related parties 2,493,088 4,714,951
Accrued expenses 7,516,940 7,984,109
Accrued acquisition cost 1,007,380 -
Taxes Payable 4,171,826 5,436,041
Deferred revenue 314,876 -
Lines of credit 8,451,025 -
Notes payable, current portion 28,982,331 8,321,298
Notes payable to related parties, current portion 2,798,783 4,027,650
Capital lease obligations, current portion 5,943,685 11,591,999
Capital lease obligation to related party, current portion 239,409 137,076
Total current liabilities 73,794,063 57,036,632
Lines of credit - 8,450,000
Notes payable, less current portion 8,459,474 5,487,939
Notes payable to related parties, less current portion 1,983,514 2,087,241
Capital lease obligations, less current portion 34,893 532,805
Capital lease obligation payable to related party, less current portion 30,803,450 31,042,859
Total liabilities 115,075,394 104,637,476
Commitments and contingencies - -
Shareholders' equity (deficit)
Preferred stock, $0.001 par value, 20,000,000 shares authorized, 3,000 shares issued and outstanding 3 3
Common stock, $0.001 par value, 480,000,000 shares authorized; 276,395,895 and 151,498,884 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 283,440 152,501
Additional paid in capital 49,078,223 12,068,748
Shareholders' receivables (2,219,068 ) -
Accumulated deficit (52,883,027 ) (50,311,832 )
Total shareholders' deficit (5,740,429 ) (38,090,580 )
Non-controlling interest 5,332,960 -
Total equity (deficit) (407,469 ) (38,090,580 )
Total liabilities and shareholders' equity (deficit) $ 114,667,925 $ 66,546,896
Consolidated Statements of Operations
Twelve Months Ended
December 31,
2011 2010
Net patient service revenues, net of contractual Adjustments $ 68,302,619 $ 55,929,507
Resident revenues 3,564,514 -
Revenue cycle revenues 465,639 -
Other revenues 174,211 205,042
Total revenues 72,506,983 56,134,549
Operating expenses
Salaries, benefits, and other employee costs 29,157,012 19,902,304
Medical supplies 13,202,829 11,314,219
Management fees for third party 5,346,456 2,597,546
General and administrative expenses 18,078,907 11,347,868
Bad debt expense 1,332,434 3,439,321
Gain on extinguishment of liabilities (4,441,449 ) (2,781,917 )
Depreciation and amortization 7,336,710 6,952,007
Total operating expenses 70,012,899 52,771,348
Operating income 2,494,084 3,363,201
Interest expense (4,938,603 ) (4,782,168 )
Other Income 500,000 -
Income (loss) before income tax (1,944,519 ) (1,418,967 )
State income tax expense 443,862 300,000
Income (loss) before non-controlling interest $ (2,388,381 ) (1,718,967 )
Net income attributable to non-controlling interests (182,814 ) -
Net income (loss) attributable to Company $ (2,571,195 ) $ (1,718,967 )
Basic and diluted earnings (loss) per share data:
Basic and diluted earnings (loss) per share $ (0.01 ) $ (0.01 )
Basic and diluted weighted average shares outstanding 254,401,405 123,583,509
Consolidated Statements of Cash Flows
Twelve Months Ended
December 31,
2011 2010
Operating activities
Net income (loss) $ (2,388,381 ) $ (1,718,967 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Bad debt expense 7,336,710 6,952,007
Depreciation and amortization 1,332,434 3,439,321
Gain (loss) on sales of assets 500,000 10,170
Gain on extinguishment of liabilities (4,441,449 ) (2,781,917 )
Net changes in other operating assets and liabilities:
Accounts receivable (3,567,069 ) (4,624,256 )
Related party receivables and payables 202,681 (595,627 )
Inventories (142,442 ) (540,495 )
Prepaid expenses and other assets (587,189 ) (37,782 )
Accounts payable, accrued expenses, and payable to Internal Revenue Service (77,842 ) 2,948,352
Deferred revenue 290,501 -
Net cash (used in) provided by operating activities (2,542,046 ) 3,050,806
Investing activities
Purchase of property and equipment (831,107 ) (276,516 )
Business acquisitions, net of cash acquired 211,910
Investments in unconsolidated affiliates (187,323 ) -
Net cash used in investing activities (806,520 ) (276,516 )
Financing activities
Redemption of common stock (50,000 ) (50,000 )
Issuance of common stock 7,298,000 3,830,000
Borrowings under notes payable 2,717,662 519,982
Payments on notes payable (5,779,381 ) (1,148,782 )
Payments on debt issuance costs (425,000 ) -
Borrowings under notes payable to related party 3,944,633 130,000
Payments on notes payable to related party (2,138,171 ) (924,581 )
Payments on capital leases (3,835,837 ) (2,776,475 )
Payments on capital lease obligation to related party (137,076 ) (64,320 )
Net cash provided by (used in) financing activities 1,594,830 (484,176 )
Net (decrease) increase in cash and cash equivalents (1,753,736 ) 2,290,114
Cash and cash equivalents at beginning of period 2,291,754 1,640
Cash and cash equivalents at end of period $ 538,018 $ 2,291,754
Supplemental disclosure of cash flow information
Interest paid $ 1,975,813 $ 3,829,791
Taxes paid $ 628,040 $ -
Supplemental noncash investing activities
Property and equipment additions financed $ - $ 682,704
Supplemental noncash financing activities
Transfer of accrued interest to capital lease obligations $ - $ 476,014
Assumption of notes payable with a corresponding related party note receivable $ - $ 100,000
Exchange of debt for common stock on February 2011 $ 3,500,000 $ -
Issuance of common stock on February 2011 $ 2,219,068 $ -
Issuance of common stock to affiliate for termination of service agreement $ 1,000,000 $ -
Noncash consideration paid for acquisitions $ 26,171,189 $ -
Transfer of accrued interest, accounts payables and capital lease obligation to debt obligation $ 5,177,912 $ -
Adjusted EBITDA Calculation
Twelve Months Ended December 31,
2011 2010
Net income (loss) $ (2,571,195 ) (1,718,967 )
Provision (benefit) for income taxes 443,862 300,000
Other non-operating expense (income) (500,000 ) -
Interest expense:
Debt and lease obligations 4,938,603 4,782,168
Interest income - -
Depreciation and amortization 7,336,710 6,952,007
Adjusted EBITDA 9,647,980 10,315,208

Contact Information

  • For Additional Information, Please Contact:

    Donald Sapaugh
    (713) 375-7557

    R. Jerry Falkner, CFA
    RJ Falkner & Company, Inc.
    Investor Relations Counsel
    (830) 693-4400

    Michael Porter
    President, Porter, LeVay & Rose
    Investor Relations